Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

NCT03007888 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.

NCT NCT03007888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03007888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
Lead sponsor
Impax Laboratories, LLC
Phase
Phase 2
Overall status
Completed
Start date
November 14, 2016
Completion date
August 1, 2017
Enrollment
28 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

advanced parkinson's disease